Showing results (221-230 of 335) with videos related to

Sort By:
Pageof 34
Cancer|July 22, 2014
Dual blockade of epidermal growth factor receptor and insulin-like growth factor receptor-1 signaling in metastatic pancreatic cancer: phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotinib (SWOG S0727)Philip A Philip, Bryan Goldman, Ramesh K Ramanathan, et al.
British Journal of Clinical Pharmacology|March 25, 2020
Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumoursDevalingam Mahalingam, Manish R Patel, Jasgit C Sachdev, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 9, 2005
Associations between plasma insulin-like growth factor proteins and C-peptide and quality of life in patients with metastatic colorectal cancerJeffrey A Meyerhardt, Jeffrey A Sloan, Daniel J Sargent, et al.
Cancer Chemotherapy and Pharmacology|March 28, 2012
Population pharmacokinetic analysis of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in adult patients with solid tumorsAbdulateef O Aregbe, Eric A Sherer, Merrill J Egorin, et al.
Cancer Chemotherapy and Pharmacology|August 24, 2004
Pharmacokinetic studies of 9-nitrocamptothecin on intermittent and continuous schedules of administration in patients with solid tumorsLaura L Jung, Ramesh K Ramanathan, Merrill J Egorin, et al.
Clinical Pharmacology and Therapeutics|August 14, 2009
Pharmacokinetic study of pegylated liposomal CKD-602 (S-CKD602) in patients with advanced malignanciesW C Zamboni, S Strychor, L Maruca, et al.
American Journal of Clinical Oncology|October 4, 2005
A phase I/II study of trimetrexate and capecitabine in patients with advanced refractory colorectal cancerKhalid Matin, Samuel A Jacobs, Thomas Richards, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2005
Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741T Delaunoit, S R Alberts, D J Sargent, et al.
Cancer Immunology, Immunotherapy : CII|September 17, 2004
Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancerRamesh K Ramanathan, Kenneth M Lee, John McKolanis, et al.
Cancer Chemotherapy and Pharmacology|January 1, 2013
A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignanciesJohn F Deeken, Rebecca Slack, Glen J Weiss, et al.
Pageof 34